Structural organization and sequence of CLN2, the defective gene in classical late infantile neuronal ceroid lipofuscinosis

被引:51
|
作者
Liu, CG
Sleat, DE
Donnelly, RJ
Lobel, P [1 ]
机构
[1] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA
[2] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA
[3] Univ Med & Dent New Jersey, New Jersey Med Sch, Lab Med & Pathol, Mol Biocore Facil, Newark, NJ 07103 USA
关键词
D O I
10.1006/geno.1998.5328
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Mutations in the CLN2 gene result in classical late infantile neuronal ceroid Iipofuscinosis (LINCL), a fatal childhood neurodegenerative disease. In this report, we present the complete sequence of the human CLN2 gene and define its physical relationship with two other genes that have been previously mapped to chromosome 11p15. The CLN2 gene consists of 13 exons and 12 introns and spans 6.65 kh. By SP mapping and primer extension, the 5'-terminus of the CLN2 mRNA was mapped to 32 nucleotides upstream of the proposed initiation codon. A number of other elements were found to be located in close proximity to CLN2, including the gene encoding transcription factor TAF(II)30, the gene encoding intregrin-linked kinase, and an similar to 914-bp fragment that is 82% identical to antithrombin III. In addition, an EST cDNA clone that is transcribed on the strand opposite to CLN2 and that overlaps a portion of the CLN2 gene was-identified. Finally, a set of primer pairs are presented for the amplification of the coding sequences, putative promoter, and splice junctions of the CLN2 gene. Taken together, this information will facilitate the molecular analysis of and genetic testing for classical LINCL. (C) 1998 Academic Press.
引用
收藏
页码:206 / 212
页数:7
相关论文
共 50 条
  • [21] Strategies to shorten diagnostic delays for late infantile neuronal ceroid lipofuscinosis type 2 (CLN2 disease)
    Mazurkiewicz-Beldinska, Maria
    del Toro, Mireia
    Hahn, Andreas
    Haliloglu, Goknur
    Huidekop, Hidde
    Kravljanac, Ruzica
    Muhlhausen, Chris
    Andersen, Brian Nauheimer
    Prpic, Igor
    Striano, Pasquale
    Auvin, Stephane
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S106 - S107
  • [22] Current understanding of language development in late infantile neuronal ceroid lipofuscinosis type 2 (CLN2 disease)
    Nickel, Miriam
    Specchio, Nicola
    Greenaway, Rebecca
    Hamborg, Christiane
    Ragno, Benedetta
    Ribitzki, Tanja
    Tondo, Ilaria
    Gissen, Paul
    Schulz, Angela
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S116 - S116
  • [23] Characterisation of Late Infantile Neuronal Ceroid Lipofuscinosis gene CLN7
    O'Hare, Megan
    Tuxworth, Richard
    Tear, Guy
    JOURNAL OF NEUROGENETICS, 2010, 24 : 57 - 58
  • [24] GENOME-WIDE SEARCH FOR CLN2, THE GENE CAUSING LATE-INFANTILE NEURONAL CEROID-LIPOFUSCINOSIS (LNCL)
    HAINES, JL
    BOUSTANY, RMN
    WORSTER, T
    TERMINASSIAN, M
    JONDRO, P
    LERNER, TJ
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1995, 57 (02): : 344 - 347
  • [25] A novel CLN2/TPP1 mutation in a Chinese patient with late infantile neuronal ceroid lipofuscinosis
    Yu-Liang Wang
    Zhi-Yong Zeng
    Xing-Wang Song
    Zhuo-Fang Hao
    Yi-Wu Shi
    Bin Tang
    Sheng-Qiang Chen
    Mei-Mei Gao
    Wei Di
    Yue-Sheng Long
    Yong-Hong Yi
    Wei-Ping Liao
    neurogenetics, 2011, 12 : 93 - 95
  • [26] VALPROIC ACID EXTENDS LIFESPAN OF THE ZEBRAFISH MODEL OF CLN2 DISEASE (LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS)
    Mahmood, Fahad
    Zdebik, Anselm
    Au, Alexandra
    Cooke, Jennifer
    Russell, Claire
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015, 86 (11):
  • [27] A novel CLN2/TPP1 mutation in a Chinese patient with late infantile neuronal ceroid lipofuscinosis
    Wang, Yu-Liang
    Zeng, Zhi-Yong
    Song, Xing-Wang
    Hao, Zhuo-Fang
    Shi, Yi-Wu
    Tang, Bin
    Chen, Sheng-Qiang
    Gao, Mei-Mei
    Di, Wei
    Long, Yue-Sheng
    Yi, Yong-Hong
    Liao, Wei-Ping
    NEUROGENETICS, 2011, 12 (01) : 93 - 95
  • [28] Economic analysis of cerliponase alfa for treatment of late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2)
    Gutic, Medo
    Milosavljevic, Milos N.
    Safiye, Teodora
    Milidrag, Ardea
    Jankovic, Slobodan M.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (05) : 561 - 570
  • [29] Multifocal retinopathy in Dachshunds with CLN2 neuronal ceroid lipofuscinosis
    Whiting, Rebecca E. H.
    Pearce, Jacqueline W.
    Castaner, Leilani J.
    Jensen, Cheryl A.
    Katz, Rebecca J.
    Gilliam, Douglas H.
    Katz, Martin L.
    EXPERIMENTAL EYE RESEARCH, 2015, 134 : 123 - 132
  • [30] Characterization and chromosomal mapping of a mouse ortholog of the late-infantile ceroid-lipofuscinosis gene CLN2
    Martin L. Katz
    Po-Ching Liu
    Sarah E. Grob-Nunn
    Hisashi Shibuya
    Gary S. Johnson
    Mammalian Genome, 1999, 10 : 1050 - 1053